Medtronic Eyes Type 2 Diabetes Monitoring

by Jonathan Collins | 3Q 2016 | IN-4144

In May, Medtronic announced a partnership with Qualcomm Life that will see the two companies developing a wearable, continuous glucose monitoring (CGM) device for type 2 diabetes sufferers. Existing CGM devices, target only the far smaller type 1 diabetes population.

You must be a subscriber to view this Insight.

To find out more about subscribing:
Contact a representative about purchasing options.